Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 2.329 | 103 | 75 | 194 | 9712 | 1095 | 185 | 5.45 | 129.49 | |
2 | Current Gene Therapy | journal | 1.983 Q1 | 80 | 44 | 129 | 5188 | 719 | 126 | 5.86 | 117.91 | |
3 | Current Alzheimer Research | journal | 1.864 Q1 | 103 | 73 | 214 | 4594 | 1033 | 202 | 5.18 | 62.93 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 1.772 Q1 | 96 | 52 | 150 | 4787 | 614 | 134 | 3.85 | 92.06 | |
5 | Current Protein and Peptide Science | journal | 1.600 Q1 | 96 | 55 | 139 | 5811 | 609 | 132 | 4.35 | 105.65 | |
6 | Current Topics in Medicinal Chemistry | journal | 1.542 Q1 | 133 | 143 | 505 | 12891 | 2045 | 435 | 3.91 | 90.15 | |
7 | Current Diabetes Reviews | journal | 1.231 Q1 | 68 | 35 | 115 | 2847 | 392 | 111 | 3.09 | 81.34 | |
8 | Infectious Disorders - Drug Targets | journal | 1.170 Q1 | 61 | 53 | 96 | 5332 | 289 | 86 | 2.78 | 100.60 | |
9 | Current Stem Cell Research and Therapy | journal | 1.088 Q1 | 63 | 33 | 101 | 3174 | 369 | 101 | 3.13 | 96.18 | |
10 | Current Vascular Pharmacology | journal | 1.046 Q1 | 69 | 56 | 109 | 6582 | 355 | 102 | 3.15 | 117.54 | |
11 | Current Neurovascular Research | journal | 1.042 | 60 | 32 | 101 | 1607 | 345 | 95 | 3.46 | 50.22 | |
12 | Current Neuropharmacology | journal | 1.038 Q1 | 103 | 35 | 81 | 3841 | 197 | 79 | 2.09 | 109.74 | |
13 | Reviews on Recent Clinical Trials | journal | 0.987 Q1 | 35 | 26 | 85 | 1496 | 253 | 80 | 3.15 | 57.54 | |
14 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 Q1 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | |
15 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q1 | 52 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | |
16 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.923 Q2 | 63 | 31 | 112 | 3909 | 291 | 109 | 2.60 | 126.10 | |
17 | Current Clinical Pharmacology | journal | 0.796 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
18 | Recent Patents on CNS Drug Discovery | journal | 0.743 Q2 | 36 | 19 | 70 | 2426 | 195 | 70 | 2.89 | 127.68 | |
19 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.724 Q2 | 45 | 31 | 89 | 2650 | 210 | 88 | 2.28 | 85.48 | |
20 | Current Nanoscience | journal | 0.664 Q2 | 52 | 73 | 125 | 3658 | 245 | 122 | 1.62 | 50.11 | |
21 | Clinical Practice and Epidemiology in Mental Health | journal | 0.648 Q2 | 58 | 20 | 95 | 845 | 189 | 95 | 1.83 | 42.25 | |
22 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.628 Q2 | 43 | 30 | 99 | 3163 | 210 | 98 | 2.14 | 105.43 | |
23 | Combinatorial Chemistry and High Throughput Screening | journal | 0.619 Q2 | 70 | 101 | 256 | 5737 | 607 | 236 | 2.59 | 56.80 | |
24 | Current Genomics | journal | 0.609 Q3 | 77 | 61 | 152 | 4811 | 200 | 151 | 1.23 | 78.87 | |
25 | Recent Patents on Drug Delivery and Formulation | journal | 0.601 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
26 | Current Chemical Biology | journal | 0.502 Q2 | 26 | 29 | 25 | 3046 | 42 | 25 | 1.68 | 105.03 | |
27 | Current Psychiatry Reviews | journal | 0.493 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
28 | Current Drug Abuse Reviews | journal | 0.476 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
29 | Current Computer-Aided Drug Design | journal | 0.428 Q2 | 32 | 21 | 82 | 2108 | 135 | 76 | 1.78 | 100.38 | |
30 | Anti-Infective Agents | journal | 0.364 Q3 | 26 | 25 | 77 | 2808 | 83 | 74 | 1.20 | 112.32 | |
31 | Current Drug Safety | journal | 0.343 Q2 | 41 | 29 | 96 | 1359 | 175 | 93 | 1.81 | 46.86 | |
32 | Current Immunology Reviews | journal | 0.332 Q3 | 23 | 31 | 80 | 3569 | 51 | 78 | 0.72 | 115.13 | |
33 | Current Medical Imaging | journal | 0.283 Q3 | 37 | 34 | 108 | 1571 | 74 | 98 | 0.41 | 46.21 | |
34 | Current Nutrition and Food Science | journal | 0.258 Q3 | 32 | 29 | 104 | 2432 | 61 | 97 | 0.52 | 83.86 | |
35 | Drug Metabolism Letters | journal | 0.216 Q3 | 31 | 40 | 101 | 1169 | 70 | 99 | 0.69 | 29.23 | |
36 | Current Pharmacogenomics and Personalized Medicine | journal | 0.213 Q4 | 20 | 27 | 26 | 2321 | 16 | 26 | 0.62 | 85.96 | |
37 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.212 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
38 | Current Drug Therapy | journal | 0.209 Q3 | 20 | 27 | 50 | 1744 | 33 | 48 | 0.66 | 64.59 | |
39 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.192 Q3 | 27 | 36 | 113 | 3866 | 39 | 101 | 0.23 | 107.39 | |
40 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.184 Q3 | 17 | 27 | 125 | 2388 | 47 | 112 | 0.37 | 88.44 | |
41 | Current Rheumatology Reviews | journal | 0.179 Q3 | 29 | 40 | 135 | 2511 | 41 | 124 | 0.38 | 62.78 | |
42 | Current Cancer Therapy Reviews | journal | 0.173 Q3 | 17 | 32 | 100 | 3033 | 29 | 96 | 0.22 | 94.78 | |
43 | Current Signal Transduction Therapy | journal | 0.168 Q3 | 22 | 22 | 47 | 2387 | 18 | 47 | 0.38 | 108.50 | |
44 | Current Pediatric Reviews | journal | 0.162 Q3 | 33 | 29 | 110 | 2278 | 37 | 107 | 0.41 | 78.55 | |
45 | Current Hypertension Reviews | journal | 0.158 Q3 | 27 | 33 | 110 | 3250 | 27 | 110 | 0.17 | 98.48 | |
46 | Current Cardiology Reviews | journal | 0.154 Q3 | 58 | 43 | 103 | 3018 | 35 | 103 | 0.17 | 70.19 | |
47 | Current Women's Health Reviews | journal | 0.151 Q3 | 16 | 32 | 105 | 2201 | 17 | 95 | 0.21 | 68.78 | |
48 | Current Aging Science | journal | 0.149 Q4 | 42 | 26 | 27 | 1897 | 21 | 26 | 0.78 | 72.96 | |
49 | Current Respiratory Medicine Reviews | journal | 0.142 Q3 | 15 | 41 | 135 | 2870 | 24 | 122 | 0.21 | 70.00 | |
50 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.119 Q4 | 28 | 26 | 25 | 2466 | 5 | 25 | 0.20 | 94.85 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®